The most commonly reported side effects include gastrointestinal symptoms such as nausea, vomiting, diarrhoea, and constipation, which occur in a substantial proportion of patients, particularly during dose escalation
This ensures that dosage administration remains aligned with the patients evolving weight management needs and health profile
Injection site guidance in this article is drawn from the DailyMed label for the Retatrutide Pen
In rheumatoid arthritis (RA), overproduction of the cytokine tumor necrosis factor (TNF) is a central event in pathogenesis, and endoplasmic reticulum (ER) rich T cells are the major releasers of TNF in inflamed joints
These habits will support the medications effects and contribute to overall well-being
Gastrointestinal side effects: Nausea, vomiting, and diarrhoea which are frequently reported in trial data can lead to dehydration and electrolyte imbalances, both of which may contribute to fatigue